

Episode # 3 • 17 Jan 2025
Musculoskeletal Embolization: New Frontiers & Techniques
Ten years ago, embolizing the knee for arthritis sounded insane, Dr. Ahmed Farag reminds the room, and today the same idea is being applied to the hip, shoulder, elbow, thumb, and even the spine. In the final session of the BackTable Creator Weekend™ on musculoskeletal (MSK) embolization, interventional radiologist Dr. Kavi Krishnasamy is joined by fellow interventional radiologists Dr. Osman Ahmed and Dr. Ahmed Farag to weigh what it takes to embolize a new target responsibly: experienced operators, a multidisciplinary team that agrees every other option is exhausted, careful documentation, and patients who have already responded well.
This podcast is supported by an educational grant from Guerbet.
Timestamps
00:00 - Introduction
01:40 - Embolizing New Targets
06:42 - The Most Promising New Indications
12:32 - Changing Guidelines: Data, Training, and Sham-Controlled Trials
16:50 - Is Spinal Embolization Ready?
20:31 - Facet Arthropathy: Patient Selection and Imaging
25:36 - Innovation Versus Experimentation
32:20 - Is MSK Embolization Moving Too Fast?
34:45 - A Registry for MSK Embolization
35:59 - What Earns Society Endorsement Next?
37:56 - Final Thoughts on Emerging Therapies
39:22 - Case: Thumb Carpometacarpal Arthritis
46:47 - Closing Remarks
Resources
- Ahmed O, et al. Society of Interventional Radiology Position Statement on Genicular Artery Embolization for Symptomatic Knee Osteoarthritis. J Vasc Interv Radiol. 2026
- Correa MP, et al. 6-Month Follow-up of Lateral Femoral Circumflex Artery Embolization to Control Pain Related to Hip Osteoarthritis and Greater Trochanteric Pain Syndrome. Cardiovasc Intervent Radiol. 2022
- Allaw S, et al. Transarterial Embolization for Refractory Adhesive Capsulitis and Related Tendinopathies: A Systematic Review and Meta-Analysis. J Vasc Interv Radiol. 2026
You may also like
More about this episode
Spinal embolization for facet arthropathy offers the biggest reward and the biggest risk in MSK embolization, and Dr. Ahmed Farag and Dr. Osman Ahmed explain why it belongs in experienced hands and, ideally, on a trial. The three physicians debate whether sham-controlled trials are needed to reach other specialties' guidelines, how an outpatient practice can run formal prospective studies, whether a registry could speed the evidence, and which indication may earn society endorsement after genicular artery embolization. Dr. Farag closes with a case of selective embolization for thumb carpometacarpal arthritis through antegrade radial access.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.